6 New Ways Big Pharma Is Scheming to Make Billions at the Expense of Your Health
Continued from previous page
To sell Neurontin, Pfizer's Parke-Davis launched an elaborate "publication plan" to get marketing papers disguised as science in medical journals. In just three years, Parke-Davis planted 13 ghostwritten articles in medical journals promoting off-label uses for Neurontin including a supplement to the prestigious Cleveland Clinic Journal of Medicine that Parke-Davis made into 43,000 reprints for its reps to disseminate. See Doc, it says right here....
And there was more duplicity. In 2011, three years after its $430 million settlement, Pfizer's STEPS trial (“Study of Neurontin: Titrate to Effect, Proﬁle of Safety”) was reported to also be a con and not a scientific study; it was a sales tool created to inspire the 772 investigators participating in the trail to personally prescribe Neurontin. Recently, the new uses of Neurontin for chronic cough, menopause and insomnia are appearing in scientific literature. Why does no one seem to believe them?